Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells

SARS-CoV-2 uses ACE2 and TMPRSS2 to gain entry into the cell. However, recent studies have shown that SARS-CoV-2 may use additional host factors that are required for the viral lifecycle. Here we used publicly available datasets, CoV-associated genes, and machine learning algorithms to explore the S...

Full description

Bibliographic Details
Main Authors: Abhinandan Devaprasad, Aridaman Pandit
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/9/1757
_version_ 1797516994661056512
author Abhinandan Devaprasad
Aridaman Pandit
author_facet Abhinandan Devaprasad
Aridaman Pandit
author_sort Abhinandan Devaprasad
collection DOAJ
description SARS-CoV-2 uses ACE2 and TMPRSS2 to gain entry into the cell. However, recent studies have shown that SARS-CoV-2 may use additional host factors that are required for the viral lifecycle. Here we used publicly available datasets, CoV-associated genes, and machine learning algorithms to explore the SARS-CoV-2 interaction landscape in different tissues. We found that in general a small fraction of cells express ACE2 in the different tissues, including nasal, bronchi, and lungs. We show that a small fraction of immune cells (including T cells, macrophages, dendritic cells) found in tissues also express ACE2. We show that healthy circulating immune cells do not express ACE2 and TMPRSS2. However, a small fraction of circulating immune cells (including dendritic cells, monocytes, T cells) in the PBMC of COVID-19 patients express ACE2 and TMPRSS2. Additionally, we found that a large spectrum of cells (in tissues and circulation) in both healthy and COVID-19-positive patients were significantly enriched for SARS-CoV-2 factors, such as those associated with RHOA and RAB GTPases, mRNA translation proteins, COPI- and COPII-mediated transport, and integrins. Thus, we propose that further research is needed to explore if SARS-CoV-2 can directly infect tissue and circulating immune cells to better understand the virus’ mechanism of action.
first_indexed 2024-03-10T07:08:41Z
format Article
id doaj.art-6b0bb005c6f04f1ca00315ce412fd9f6
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T07:08:41Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-6b0bb005c6f04f1ca00315ce412fd9f62023-11-22T15:37:31ZengMDPI AGViruses1999-49152021-09-01139175710.3390/v13091757Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune CellsAbhinandan Devaprasad0Aridaman Pandit1Center for Translational Immunology, University Medical Center Utrecht, 3584 EA Utrecht, The NetherlandsCenter for Translational Immunology, University Medical Center Utrecht, 3584 EA Utrecht, The NetherlandsSARS-CoV-2 uses ACE2 and TMPRSS2 to gain entry into the cell. However, recent studies have shown that SARS-CoV-2 may use additional host factors that are required for the viral lifecycle. Here we used publicly available datasets, CoV-associated genes, and machine learning algorithms to explore the SARS-CoV-2 interaction landscape in different tissues. We found that in general a small fraction of cells express ACE2 in the different tissues, including nasal, bronchi, and lungs. We show that a small fraction of immune cells (including T cells, macrophages, dendritic cells) found in tissues also express ACE2. We show that healthy circulating immune cells do not express ACE2 and TMPRSS2. However, a small fraction of circulating immune cells (including dendritic cells, monocytes, T cells) in the PBMC of COVID-19 patients express ACE2 and TMPRSS2. Additionally, we found that a large spectrum of cells (in tissues and circulation) in both healthy and COVID-19-positive patients were significantly enriched for SARS-CoV-2 factors, such as those associated with RHOA and RAB GTPases, mRNA translation proteins, COPI- and COPII-mediated transport, and integrins. Thus, we propose that further research is needed to explore if SARS-CoV-2 can directly infect tissue and circulating immune cells to better understand the virus’ mechanism of action.https://www.mdpi.com/1999-4915/13/9/1757SARS-CoV-2ACE2immune cellsgene enrichmentT cellsmacrophages
spellingShingle Abhinandan Devaprasad
Aridaman Pandit
Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
Viruses
SARS-CoV-2
ACE2
immune cells
gene enrichment
T cells
macrophages
title Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
title_full Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
title_fullStr Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
title_full_unstemmed Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
title_short Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
title_sort enrichment of sars cov 2 entry factors and interacting intracellular genes in tissue and circulating immune cells
topic SARS-CoV-2
ACE2
immune cells
gene enrichment
T cells
macrophages
url https://www.mdpi.com/1999-4915/13/9/1757
work_keys_str_mv AT abhinandandevaprasad enrichmentofsarscov2entryfactorsandinteractingintracellulargenesintissueandcirculatingimmunecells
AT aridamanpandit enrichmentofsarscov2entryfactorsandinteractingintracellulargenesintissueandcirculatingimmunecells